Bausch Health Companies Inc.
NYSE:BHCDrug Manufacturers - Specialty & Generic
-$0.11 today
- Market cap
- $3.27B
- Beta
- 0.41
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$3.19
Volume 6.83M
Average 1.70M
BHC Weighted Avg Shares
Average number of basic shares outstanding during the period, used to calculate basic EPS.
Bausch Health Companies Inc.NYSE: BHC
Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares grows in line with its trailing trend
Q2 FY2026 weighted avg shares of 375M shares rose 1.1% year over year, ahead of the +0.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +0.8% a year.
Context
- Weighted avg shares increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +1.1% holds above the trailing-twelve-month pace of +0.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares history
Shares · from the income statement
- Latest · FY2025
- 370.9M USD
- Year-over-year change
- +0.8%
- 4-year CAGR
- +0.8%
| Period | Period end | Weighted Avg Shares | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 370.9M | +0.8% |
| FY2024 | 2024-12-31 | 368M | +0.8% |
| FY2023 | 2023-12-31 | 364.9M | +0.8% |
| FY2022 | 2022-12-31 | 362M | +0.9% |
| FY2021 | 2021-12-31 | 358.9M | — |
Weighted Avg Shares vs competitors
How BHC compares with its peers on the latest reported figures
- BHC's LTM Jun 2026 weighted avg shares of 372.41M shares is the highest of the 11 companies compared; the peer median is 124.54M shares.
- Its year-over-year change of +0.6% is the 8th highest of 11, against a peer median of +3.1%.
- Over three fiscal years its annual growth of +0.8% compares with a peer median of +3.4%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | 372.41M | +0.6% | +0.8% | |
| LTM Mar 2026 | 297.74M | +6.2% | +12.2% | |
| LTM Jun 2025 | 206.7M | +20.7% | +0.4% | |
| LTM Mar 2026 | 199.58M | -1.3% | -2.6% | |
| LTM Jun 2026 | 138.7M | +0.7% | +1.0% | |
CONConcentra Group Holdings Parent, Inc. | LTM Sep 2026 | 126.76M | -0.2% | +0.0% |
| LTM Mar 2026 | 122.33M | +2.3% | +5.8% | |
| LTM Jun 2026 | 103.26M | +16.4% | +12.2% | |
| LTM Jun 2026 | 79.68M | +45.9% | +135.7% | |
| LTM Jun 2026 | 46.49M | -6.3% | -2.4% | |
| LTM Mar 2026 | 20.22M | +4.0% | +7.2% | |
| Peer median (excluding BHC) | 124.54M | +3.1% | +3.4% | |
Competitors are the stored peer set for BHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 8.43B | 8.12B | 8.76B | 9.63B | 10.27B |
| Cost of Revenue | 2.39B | 2.36B | 2.56B | 2.78B | 3.01B |
| Gross Profit | 6.04B | 5.76B | 6.2B | 6.84B | 7.25B |
| Gross Margin | 71.6% | 70.9% | 70.8% | 71.1% | 70.7% |
| Research & Development | 473M | 530M | 604M | 634M | 629M |
| Selling, General & Admin | 2.49B | 2.53B | 2.9B | 3.28B | 3.44B |
| Operating Expenses | 5.59B | 5.31B | 5.24B | 5.3B | 5.07B |
| Depreciation & Amortization | 1.55B | 1.39B | 1.26B | 1.27B | 1.21B |
| EBITDA | 3.26B | 2.88B | 2.89B | 3.13B | 3.18B |
| EBITDA Margin | 38.7% | 35.4% | 32.9% | 32.6% | 31.0% |
| Operating Income | 450M | 454M | 963M | 1.55B | 2.19B |
| Operating Margin | 5.3% | 5.6% | 11.0% | 16.1% | 21.3% |
| Interest Income | 7M | 14M | 26M | 33M | 48M |
| Interest Expense | 1.43B | 1.46B | 1.33B | 1.39B | 1.6B |
| Other Income / Expenses | (1.47B) | (583M) | (1.35B) | (1.38B) | (1.82B) |
| Income Before Tax | (1.02B) | (129M) | (390M) | 167M | 367M |
| Pre-Tax Margin | -12.1% | -1.6% | -4.5% | 1.7% | 3.6% |
| Income Tax Expense | (87M) | 83M | 221M | 239M | 247M |
| Net Income | (948M) | (225M) | (592M) | (46M) | 157M |
| Net Margin | -11.2% | -2.8% | -6.8% | -0.5% | 1.5% |
| EPS (Basic) | (2.61) | (0.62) | (1.62) | (0.13) | 0.43 |
| EPS (Diluted) | (2.61) | (0.62) | (1.62) | (0.13) | 0.43 |
| Weighted Avg Shares | 358.9M | 362M | 364.9M | 368M | 370.9M |
| Weighted Avg Shares (Diluted) | 358.9M | 362M | 364.9M | 368M | 375M |
Bausch Health Companies Inc.
NYSE:BHC
Intrinsic Alpha fair value
Locked
Current Price
$8.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.